Leveraging Alternative Payment Models to Ensure Broad Access to Personalized Medicine

Register Now

Wednesday, June 3 | 12:00 - 12:30 PM EASTERN TIME (ET)

Rena Conti

Professor, Markets, Public Policy, and Law, Boston University Questrom School of Business

Alex Clemente

Managing Director, HBR-AS

Personalized medicine, driven by scientific innovation, is reshaping healthcare. Today, these therapies typically target rare diseases, but their promise is to improve population health by matching patients with a therapy created just for them, which is more targeted, more effective, and less toxic.

However, estimates put the cost of developing a personalized treatment at $800 million to $2.6 billion. This high cost creates uncertain reimbursement, which limits access to these therapies and is a barrier to investment in new therapies.

A recent HBR Analytic Services White Paper, sponsored by BU Questrom School of Business, explored alternative payment models to ensure broad access to personalized medicine.

In this webinar, HBR-AS’s Alex Clemente will share insights from the HBR-AS White Paper and BU professor Rena Conti will describe research at Questrom on innovative funding models, such as value-based agreements and performance risk sharing. They will discuss:

What personalized medicine is, why it is so important, and why it is growing
Hurdles that limit access to precision therapies and innovation and investment in them
Alternative funding models, including value-based arrangement and subscription models, with the potential to overcome these barriers
Real-world examples where these models are being applied

Personalized medicine promises to play a significant role in the future of health care, but achieving this promise requires overcoming financial barriers that impede access and stifle innovation.

To learn about strategies for overcoming these barriers, join Rena Conti, Alex Clemente, and HBR Analytic Services on June 3.

Can’t join us live? Register anyway, and we’ll send you the recording.

Register Now

Sponsored by Boston University Questrom School of Business

You are receiving this because you registered at hbr.org to receive Webinars emails, or you provided us with your email address.

If you prefer not to receive Webinars emails, please unsubscribe.

You may also Manage Email Preferences, view our Privacy Policy, or Contact Us.

To ensure email delivery, add emailteam@emails.hbr.org to your address book, contacts, or safe sender list.